Ciera Mangone

发表

18F-FluorThanatrace (18F-FTT) positron emission tomography (PET/CT) in prostate cancer measures in vivo PARP-1 expression and is associated with adverse clinicopathologic features.

R. Mach, D. Pryma, E. Schubert, 2022, Journal of Clinical Oncology.